Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Level2View

AQST
Aquestive Therapeutics, Inc. Common Stock
stock NASDAQ

Market Open
Oct 1, 2026 2:58:08 PM EDT
4.51USD-2.592%(-0.12)1,696,746
4.51Bid   4.52Ask   0.01Spread
Pre-market
Oct 1, 2026 9:29:30 AM EDT
4.55USD-1.728%(-0.08)9,586
After-hours
Sep 30, 2026 4:28:30 PM EDT
4.62USD-0.216%(-0.01)0
OverviewOption ChainMax PainOptionsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsTrends
AQST Reddit Mentions
Subreddits
Limit Labels     

We have sentiment values and mention counts going back to 2017. The complete data set is available via the API.
Take me to the API
AQST Specific Mentions
As of Oct 1, 2026 2:57:38 PM EDT (1 min. ago)
Includes all comments and posts. Mentions per user per ticker capped at one per hour.
5 days ago • u/tlktchr1 • r/biotech_stocks • my_biotech_watchlist_some_must_buy_right_now • C
Here’s one. Burned me once, with an FDA rejection (CRL), but the rejection was based on pachaging, not the drug. AQST is the company, Anaphylm is the drug. It’s epinephrine for severe life threatening allergic reactions, it will replace the epi-pen when approved, and the new nasal spray Neffy from ARM pharm. this is a little film that dissolves under the tongue, tiny package, people will carry it and it will be a big deal. AQST just resubmitted their NDA on it, after doing two successful studies to fix the packaging issues. So, FDA will decide now on an expedited decision (PDUFA) or a quick section or standard length of time decision. It will either come mid November, mid march, or mid July. We’ll know in November. Price is good, check it out. Has 95 million in financing that comes automatically when it’s approved, so they won’t dilute to start manufacturing. To me it looks like a done deal for approval, and then a massive market for it. Check it out. I have 3K in it, wish I had more to throw at it.
sentiment 0.89
5 days ago • u/tlktchr1 • r/biotech_stocks • my_biotech_watchlist_some_must_buy_right_now • C
Here’s one. Burned me once, with an FDA rejection (CRL), but the rejection was based on pachaging, not the drug. AQST is the company, Anaphylm is the drug. It’s epinephrine for severe life threatening allergic reactions, it will replace the epi-pen when approved, and the new nasal spray Neffy from ARM pharm. this is a little film that dissolves under the tongue, tiny package, people will carry it and it will be a big deal. AQST just resubmitted their NDA on it, after doing two successful studies to fix the packaging issues. So, FDA will decide now on an expedited decision (PDUFA) or a quick section or standard length of time decision. It will either come mid November, mid march, or mid July. We’ll know in November. Price is good, check it out. Has 95 million in financing that comes automatically when it’s approved, so they won’t dilute to start manufacturing. To me it looks like a done deal for approval, and then a massive market for it. Check it out. I have 3K in it, wish I had more to throw at it.
sentiment 0.89


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC